FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

(MedPage Today) — The FDA said it has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in patients with congenital thrombotic thrombocytopenic purpura (cTTP) who were treated with the recombinant ADAMTS13…

Source link : https://www.medpagetoday.com/hematologyoncology/hematology/118655

Author :

Publish date : 2025-11-21 20:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA Probes Child Death Linked to Drug for Blood Clotting Disorder

Telehealth-Based Cancer Trial; AI-Based Cancer Biomarkers; Myeloma Survival Landmark

Primary Hyperparathyroidism Tied to Long-Term Cardiometabolic Risks

Related Posts

Rare Childhood Disorder Gets Its First FDA Drug Approval

Mystery Brain Disease in Canada; Alzheimer’s Clinical Trial Lawsuit; Brains in Space

‘Misleading’ Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF

Streeting Moves to Favour UK Graduates for NHS Training

EPA Will Stop Calculating the Economic Savings to Health in Key Air Pollution Rules

Nurses Strike Enters Second Day at Major New York City Hospitals

Rare Childhood Disorder Gets Its First FDA Drug Approval

Mystery Brain Disease in Canada; Alzheimer’s Clinical Trial Lawsuit; Brains in Space

‘Misleading’ Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF

Streeting Moves to Favour UK Graduates for NHS Training

EPA Will Stop Calculating the Economic Savings to Health in Key Air Pollution Rules

Nurses Strike Enters Second Day at Major New York City Hospitals

Trump Talks About Taking GLP-1s; New MiniMed System OK’d; Testosterone in Diet Recs

The New Dietary Guidelines Serve Up a Muddled Mix of Ideology and Science

Categories

Archives